Model‐based Dose Selection to Inform Translational Clinical Oncology Development of WNT974, a First‐in‐class Porcupine Inhibitor
Clinical and Translational Science（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined